Notable Roles | - Chairperson, Biocon & Biocon Biologics (2023–present) |
Key Recognition | - India’s first female biotech entrepreneur |
Background and Early Foundations
Born in 1953 in Bangalore, India, Kiran Mazumdar Shaw trained as a brewmaster in Australia — a rare path for women in the 1970s. After facing repeated job rejections in India, she used her technical expertise to start Biocon from her garage. Initially a maker of enzymes, the company pivoted under her leadership into pharmaceuticals and biologics, becoming a symbol of scientific independence and resilience.
Career Milestones and Impact
Year | Milestone |
|---|---|
1978 | Founded Biocon India in her garage with $500 in seed capital |
2004 | Took Biocon public; became India’s first woman to lead a listed biotech firm |
2010 | Launched Biocon Foundation to drive healthcare access in rural India |
2014 | Appointed Independent Director, Infosys |
2023 | Transitioned to Chairperson role of Biocon & Biocon Biologics, focusing on global biosimilar access |
- Company Valuation (Biocon Group, 2025): ~$4.2 billion
- Biosimilars Approved Globally: 6+ in US, EU, and emerging markets
- Biocon Foundation Impact: 1M+ people across 3 Indian states
- Employees: 13,000+ across Biocon, Biocon Biologics, and Syngene
- Global Presence: Over 120 countries served
Leadership Style and Influence
Kiran Mazumdar Shaw is known for leading with vision, science-backed conviction, and social responsibility. She championed women in STEM, democratized access to cancer and diabetes treatment through affordable biosimilars, and fostered a new generation of Indian scientific entrepreneurship.
Legacy and Future Focus
Kiran’s legacy lies in building India’s biotech industry from the ground up. Her current focus is on making Biocon Biologics a world leader in biosimilar innovation and access. She continues to influence health policy, biotech regulation, and equitable R&D across the Global South.
